Şunu aradınız:: fviii (Maltaca - İngilizce)

inibizzjoni fviii
fviii inhibition

formazzjoni ta’ inibitur għal fviii
inhibitor formation to fviii

voncento 1000 iu fviii/2400 iu vwf
voncento 1000 iu fviii / 2400 iu vwf

livell fviii meħtieġ (% jew iu/dl)
factor viii level required (% or iu/dl)

livell mixtieq ta’ fviii fil-plażma
desired plasma fviii level

emofilija a (defiċjenza konġenita ta’ fviii)
haemophilia a (congenital fviii deficiency)

livell meħtieġ ta’ fviii (%) (iu/dl)
fviii level required (%) (iu/dl)

vwf u fviii huma nvoluti fit-tgħaqqid tad-demm.
vwf and fviii are involved in blood clotting.

vwf jikkawża korrezzjoni ritardata tad-defiċjenza fviii assoċjata.
vwf produces delayed correction of the associated fviii deficiency.

minbarra hekk pazjenti jistgħu jiżviluppaw inibituri għal fviii u vwf.
furthermore patients may develop inhibitors to fviii and vwf.

1000 iu* fattur tal-koagulazzjoni tal-bniedem viii** (fviii)
1000 iu* human coagulation factor viii** (fviii)

(iu/ dl żieda fi fviii: c kull iu/ kg fviii mogħti)
(iu/ dl increase in fviii: c per iu/ kg fviii given)

rata ta ’ eliminazzjoni = rata ta ’ infużjoni/ livell ta ’ fviii reali.
subsequent infusion rates should be calculated based on the actual fviii levels and recalculated clearance for each day post surgery based on the equation: clearance = infusion rate/ actual fviii level.

irkupru (iu/dl żieda fi fviii:c kull iu/kg fviii mogħti)
recovery (iu/dl increase in fviii:c per iu/kg fviii given)

l-attività massima fid-demm ta' fviii ma għandhiex taqbeż il-200%.
the maximum blood fviii activity must not exceed 200%.

inibizzjoni fviii/vwf: il-mediċina tieqaf taħdem tajjeb (fsada kontinwa).
fviii/vwf inhibition: the medicine stops working properly (continuous bleeding).

il- frekwenza tal- impedituri ta 'fviii misjuba sa issa hija fil- medda mistennija u osservata qabel.
the frequency of fviii inhibitors detected so far is within the expected and previously observed range.

fviii derivat mill-plażma tal-bniedem mogħti b’mod exoġenu jġib ruħu fl-istess mod bħal fviii endoġenu.
exogenously administered human plasma-derived fviii behaves in the same way as endogenous fviii.

voncento 1000 iu fviii/2400 iu vwf (10 ml solvent) trab u solvent għal soluzzjoni għall- injezzjoni/infużjoni
voncento 1000 iu fviii / 2400 iu vwf (10 ml solvent) powder and solvent for solution for injection/infusion

il-kumpless fviii/vwf jikkonsisti f’żewġ molekoli (fviii u vwf) b’funzjonijiet fiżjoloġiċi differenti.
the fviii/vwf complex consists of two molecules (fviii and vwf) with different physiological functions.